Noninvasive scan to check liver fat and scarring
Part of Digestive system clinical trials.
This study tests a noninvasive FibroScan machine to help measure liver fat and possible liver scarring using information collected in a database. It may help researchers improve how liver problems like fat buildup and scarring are identified and tracked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have known or suspected risk factors for liver fat (steatosis) or liver scarring (fibrosis)
- You may have a past diagnosis of NASH but currently do not know your current fat or scarring scores
- You may have another liver condition such as hepatitis C (HCV)
- You are not pregnant
- Your BMI is less than 40
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new ultrasound technique called Visual Transient Elastography (ViTE) to measure fat and scarring in the liver. If you recently had a liver biopsy, this noninvasive test could help check your liver health without another needle procedure.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
This trial tests a special ultrasound technique during an endoscopy to see how well it can detect changes in the liver from non-alcoholic fatty liver disease. It may help improve non-invasive assessment before or alongside a follow-up liver biopsy.
This study tests two new ultrasound techniques, Attenuation Imaging and Shear Wave Elastography, during a routine endoscopic ultrasound to see if they can accurately measure liver fat and stiffness in people whose standard FibroScan is normal. It may help doctors detect early liver changes more precisely.
This trial looks for better ways to detect liver scarring (fibrosis) in people with long-term liver disease. It may help find problems earlier.
This study looks at how certain features of your metabolism affect a simple score (called the FAST score) in people with fatty liver disease (MASLD). It aims to help doctors better understand and manage the condition.
Hear when a new Disease of Liver and Bile Duct trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.